DC federal court declines restraining order sought by Apotex

The District of Columbia federal court has declined to issue a temporary restraining order and preliminary injunction sought by Apotex to stop the FDA from delaying approval of its generic form of AstraZeneca's Prilosec. Apotex had sought to defeat a pediatric exclusivity patent extension on Prilosec.
You must be a registered member of MMM to post a comment.
close

Next Article in Careers

The 2015 healthcare agency questionnaire, for firms hoping to be featured in the Top 100 Agencies issue, is live. Click here to be considered.

Email Newsletters